Tulane Medical Center

Baird Medical Expands Presence in the United States

Retrieved on: 
Wednesday, February 28, 2024
Interventional radiology, Education, MWA, Physician, FDA, Growth, Weill Cornell Medicine, Annual general meeting, Tulane Medical Center, Safety, Thyroid disease, Society, NYU Langone Health, Patient, Stanford University Medical Center, Pharmaceutical industry

FRISCO, Texas, Feb. 28, 2024 /PRNewswire/ -- Baird Medical Devices, Inc. ("Baird Medical" or the "Company"), a leading microwave ablation ("MWA") medical device developer and provider in China and the United States, today announced that it is accelerating its expansion in the United States through senior hires, key partnerships, and capacity building initiatives to support its business.

Key Points: 
  • FRISCO, Texas, Feb. 28, 2024 /PRNewswire/ -- Baird Medical Devices, Inc. ("Baird Medical" or the "Company"), a leading microwave ablation ("MWA") medical device developer and provider in China and the United States, today announced that it is accelerating its expansion in the United States through senior hires, key partnerships, and capacity building initiatives to support its business.
  • "I am very excited to join Baird Medical at this critical time," said Christian Chilcott, Chief Commercial Officer, Americas, of Baird Medical.
  • Baird Medical offers a rigorous medical education program to build industry capacity and safety as a critical part of its business development.
  • "Entering a mature medical market like the United States requires that we take our time to do it well.

FTC Sues to Stop the Potentially Illegal Integration of New Orleans Area Hospitals Over Failure to Follow Federal Reporting Law

Retrieved on: 
Thursday, April 20, 2023
Review, HSR, Hart–Scott–Rodino Antitrust Improvements Act, Lakeview Hospital, General counsel, Obstruction, Tulane Medical Center, Commission, Public, Blog, COPA, Social media, District, The Act, Federal Trade Commission, LCMC, Hospital, District court, Acquisition, Tulane–Lakeside Hospital, Compliance, FTC, HCA, Mergers and acquisitions, HCA Healthcare, Douglas v. U.S. District Court ex rel Talk America, News, Cryptocurrency

"We are seeking to hold LCMC accountable for disregarding the law by ignoring filing requirements and prematurely consummating their deal,” said FTC Chair Lina M. Khan.

Key Points: 
  • "We are seeking to hold LCMC accountable for disregarding the law by ignoring filing requirements and prematurely consummating their deal,” said FTC Chair Lina M. Khan.
  • Despite that, the agency said, LCMC and HCA consummated the transaction on January 3 without ever reporting it to the agencies.
  • The Compliance, Premerger Notification, Office of General Counsel, and Mergers IV divisions were responsible for this matter.
  • For the latest news and resources, follow the FTC on social media, subscribe to press releases and read our blog.

FTC Sues to Stop the Potentially Illegal Integration of New Orleans Area Hospitals Over Failure to Follow Federal Reporting Law

Retrieved on: 
Thursday, April 20, 2023
Review, HSR, Hart–Scott–Rodino Antitrust Improvements Act, Lakeview Hospital, General counsel, Obstruction, Tulane Medical Center, Commission, Public, Blog, COPA, Social media, District, The Act, Federal Trade Commission, LCMC, Hospital, District court, Acquisition, Tulane–Lakeside Hospital, Compliance, FTC, HCA, Mergers and acquisitions, HCA Healthcare, Douglas v. U.S. District Court ex rel Talk America, News, Cryptocurrency

"We are seeking to hold LCMC accountable for disregarding the law by ignoring filing requirements and prematurely consummating their deal,” said FTC Chair Lina M. Khan.

Key Points: 
  • "We are seeking to hold LCMC accountable for disregarding the law by ignoring filing requirements and prematurely consummating their deal,” said FTC Chair Lina M. Khan.
  • Despite that, the agency said, LCMC and HCA consummated the transaction on January 3 without ever reporting it to the agencies.
  • The Compliance, Premerger Notification, Office of General Counsel, and Mergers IV divisions were responsible for this matter.
  • For the latest news and resources, follow the FTC on social media, subscribe to press releases and read our blog.

Steve Harvey Morning Show Co-Host Kier "Junior" Spates, a Sickle Cell Warrior, Hosts the New Inspiring Podcast, "Living Your Life"

Retrieved on: 
Monday, April 17, 2023
Universe, Vicar Hope Foundation, Living, Sister, Sister, National Geographic, IBM, Travel, Food, Gulf Coast of the United States, Use, Steve Harvey (talk show), Education, Sickle cell trait, LSU Health Sciences Center New Orleans, 47th NAACP Image Awards, Ford, Constipation, Chest pain, Cell, Macdonald, CBS, Family Feud, NBC, CNN, Cough, Assistant, Pain, Today, New Year, Good Morning America, Back pain, Living Your Life, Prairie View A&M University, New Year's Eve, Tulane Medical Center, The Jamie Foxx Show, COVID-19, Genetic disorder, Think Like a Man, Sickle cell disease, Nausea, Live Your Life (Yuna song), FDA, Headache, State Farm, Television, Dillard University, Pharmaceutical industry, Glutamine, The Walt Disney Company

The series, Living Your Life, brings attention to families and individuals thriving despite sickle cell disease or sickle cell trait.

Key Points: 
  • The series, Living Your Life, brings attention to families and individuals thriving despite sickle cell disease or sickle cell trait.
  • The podcast premiers Tuesday, April 18th and can be found on YouTube and at https://livingyourlife.online .
  • Each episode will provide positive lifestyle stories and information about sickle cell, including health care, travel, and food.
  • Living Your Life focuses on increasing awareness for sickle cell disease and improving patient outcome.

ReSuture, Inc. Awarded $996,413 NSF Phase II Small Business Innovation Research Grant to Support Surgical Performance and Medical Device Development

Retrieved on: 
Monday, March 6, 2023
ASU, Arizona State University, SBIR, NSF, Surgeon, Perioperative, Machine learning, McMaster University, Mayo Clinic, Computer science and engineering, National Science Foundation, Algorithm, Orgasmatron (massage device), Data analysis, Teleflex, Computer science, Clinical professor, Tulane Medical Center, BD (company), Capacitive sensing, Medical device

The grant will support commercialization of ReSuture's products and technology to evaluate vascular surgical operative performance in both open and endovascular fields.

Key Points: 
  • The grant will support commercialization of ReSuture's products and technology to evaluate vascular surgical operative performance in both open and endovascular fields.
  • The grant, entitled "SBIR Phase II: Quantification of Operative performance through Simulated Surgical Platforms, Capacitive Sensing, and Machine Learning to Improve Surgeon Performance and Medical Device Development," will be conducted in conjunction with Arizona State University (ASU).
  • Gore, Teleflex Medical, Becton Dickinson, Endologix, and surgical residency programs at Tulane Medical Center, McMaster University, and the Mayo Clinic.
  • This NSF Phase II funding represents a tremendous opportunity for further development and commercial scaling of our products that can improve surgical training and revolutionize development pipelines in the medical device industry.

LCMC Health and Tulane University Finalize Partnership

Retrieved on: 
Tuesday, January 3, 2023
Organization, Hospital, Association of American Universities, Patient, Charity Hospital, Tulane Medical Center, Carnegie Foundation, Children's Hospital of New Orleans, Touro, Tulane–Lakeside Hospital, Foundation (nonprofit), Student, East Jefferson General Hospital, Lakeview Regional Medical Center, University Hospital, New Orleans, West Jefferson Medical Center, Partnership, Charity Hospital (New Orleans), Growth, Gulf Coast of the United States, Health, Education, Justice, LCMC, Medicine, Louisiana Department of Health, Public health, Carnegie Foundation for the Advancement of Teaching, HCA, Friends, Entrepreneurship, Multimedia, University Medical Center New Orleans, Social work, Tulane University School of Medicine, Physician, Research, LCMC Health System, Health insurance, Pharmaceutical industry, Tulane University

NEW ORLEANS, Jan. 3, 2023 /PRNewswire/ -- LCMC Health and Tulane University today announced that the organizations have finalized their partnership, following approval from the Louisiana Department of Justice. Through this partnership, Tulane Medical Center, Lakeview Regional Medical Center, and Tulane Lakeside Hospital will join LCMC Health.

Key Points: 
  • NEW ORLEANS, Jan. 3, 2023 /PRNewswire/ -- LCMC Health and Tulane University today announced that the organizations have finalized their partnership, following approval from the Louisiana Department of Justice.
  • Through this partnership, Tulane Medical Center, Lakeview Regional Medical Center, and Tulane Lakeside Hospital will join LCMC Health.
  • "The shared vision between LCMC Health and Tulane University to provide unparalleled patient care and medical research advancements in Southeast Louisiana made this partnership a natural fit," said LCMC Health CEO Greg Feirn.
  • "I can't overstate how important this partnership will be to improving healthcare and boosting medical research in our community," Tulane University President Michael A. Fitts said.

Arzu Hatipoglu, MD is recognized by Continental Who's Who

Retrieved on: 
Thursday, January 27, 2022
American Board of Internal Medicine, Patient, University School, MD, American Board of Commissioners for Foreign Missions, Northwest Kidney Centers, Nephrology, Continental, Internal medicine, Adult, Medicine, Knowledge, ABIM, Tulane Medical Center, Louisiana State University School of Medicine, Perseverance, Hospital

METAIRIE, La., Jan. 27, 2022 /PRNewswire/ --Arzu Hatipoglu, MD, is being recognized by Continental Who's Who as a Distinguished Nephrologist for her professional excellence in the field of medicine and her medical contributions at the Metropolitan Kidney Centers.

Key Points: 
  • METAIRIE, La., Jan. 27, 2022 /PRNewswire/ --Arzu Hatipoglu, MD, is being recognized by Continental Who's Who as a Distinguished Nephrologist for her professional excellence in the field of medicine and her medical contributions at the Metropolitan Kidney Centers.
  • Dr. Arzu Hatipoglu, a board-certified nephrologist, has devoted 22 years to serving the medical community and caring for her patients with the Metropolitan Kidney Centers.
  • She demonstrates proven knowledge and experience in adult internal medicine and pediatric medicine.
  • Similar to the mission of the Kidney Centers, Dr. Hatipoglu is committed to serving the families of south Louisiana and providing quality dialysis services.

TopAlliance Appoints Virginia Ellen Maher, MD, as Vice President of Medical Sciences

Retrieved on: 
Monday, November 1, 2021
Center for Biologics Evaluation and Research, CDER, Oncology Drug Advisory Committee, Eli Lilly, Temple University School of Medicine, University, R & D, Tulane Medical Center, Hematology, Microbiology, EUA, Bamlanivimab, FDA, MedStar Washington Hospital Center, NMPA, Food, Severe acute respiratory syndrome coronavirus 2, Cell, Review, Center, Physician, VP, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Infection, National, HKEX, Pazopanib, Marketing, Bamlanivimab/etesevimab, Center for Drug Evaluation and Research, SSE, Crizotinib, Executive director, Gene, National Cancer Institute, Division, Institute, Therapy, Bevacizumab, Autoimmunity, GLOBE, Medical device, Pharmaceutical industry

SHANGHAI, China, Nov. 01, 2021 (GLOBE NEWSWIRE) -- TopAlliance Biosciences, a wholly own subsidiary of Junshi Biosciences (HKEX: 1877; SSE: 688180) today announced the appointment of Dr. Virginia Ellen Maher as VP of Medical Sciences, reporting to the company's Chief Medical Officer Dr. Patricia Keegan.

Key Points: 
  • SHANGHAI, China, Nov. 01, 2021 (GLOBE NEWSWIRE) -- TopAlliance Biosciences, a wholly own subsidiary of Junshi Biosciences (HKEX: 1877; SSE: 688180) today announced the appointment of Dr. Virginia Ellen Maher as VP of Medical Sciences, reporting to the company's Chief Medical Officer Dr. Patricia Keegan.
  • Prior to joining TopAlliance, she served as the Executive Director and Principal Clinical Consultant at DataRevive, a biopharmaceutical regulatory consulting firm.
  • Before joining the FDA, Dr. Maher worked at the Schering-Plough Institute, the National Cancer Institute, and the Tulane Medical Center.
  • She then completed her medical residency at the Washington Hospital Center and her Hematology/Medical Oncology fellowship at the University of Massachusetts Medical Center.

Fractyl Announces Tenth Trial Site Opened in REVITA-T2Di Study of Revita® DMR for Type 2 Diabetes

Retrieved on: 
Wednesday, September 1, 2021
Biotechnology, Pharmaceutical, Health, Clinical Trials, Union, Microdeletion syndrome, Indiana University Health, Alliance of Independent Academic Medical Centers, Diabetes, Lists of diseases, Duodenum, Physician, European Union, Tulane University School of Medicine, Beth Israel Deaconess Medical Center, Tulane Medical Center, Glycated hemoglobin, Marketing, BDD, Erasmus Hospital, Weight gain, Academic Medical Center (Amsterdam), Clinical trial, Risk, Insulin resistance, Patient, Hypoglycemia, IDE, Investigational device exemption, Insulin, FDA, Type 2 diabetes, NCT, Health, Pharmaceutical industry, the RevitaⓇ DMR Treatment, Fractyl Health, THE REVITAⓇ DMR TREATMENT, FRACTYL HEALTH

We are grateful to the prestigious medical centers who have partnered with us to carry out this study, said Juan Carlos Lopez-Talavera, M.D., Ph.D., chief medical officer of Fractyl.

Key Points: 
  • We are grateful to the prestigious medical centers who have partnered with us to carry out this study, said Juan Carlos Lopez-Talavera, M.D., Ph.D., chief medical officer of Fractyl.
  • Fractyl has obtained Breakthrough Device Designation from the FDA for Revita DMR in the insulin-treated T2D patient population.
  • It will evaluate the efficacy of Revita DMR (duodenal mucosal resurfacing), a first-in-class intervention targeting the role of the duodenum in metabolic disease.
  • Fractyls lead program is Revita DMR, an outpatient endoscopic procedural therapy designed to treat insulin resistance in T2D.